Related Experiment Videos

Vitamin A and preterm infants: what we know, what we don't know, and what we need to know

H Mactier1, L T Weaver

  • 1Princess Royal Maternity and Division of Developmental Medicine, University of Glasgow, 8-16 Alexandra Parade, Glasgow G31 2ER, Scotland, UK. helen.mactier@northglasgow.scot.nhs.uk

Archives of Disease in Childhood. Fetal and Neonatal Edition
|February 23, 2005
PubMed

Insights

Vitamin A is crucial for infant development. Supplementation reduces mortality in newborns, but optimal strategies for extremely preterm infants require further study.

Area of Science:

  • Neonatal nutrition
  • Vitamin A metabolism
  • Pediatric intensive care

Background:

  • Vitamin A is vital for growth and development.
  • Vitamin A supplementation in newborns reduces mortality in developing nations.
  • Extremely preterm infants in developed countries have low vitamin A stores and are at high risk of deficiency.

Purpose of the Study:

  • To review the current understanding of vitamin A supplementation in extremely preterm infants.
  • To highlight the lack of defined optimal supplementation protocols for this vulnerable population.
  • To emphasize the need for further research into vitamin A status and long-term outcomes in preterm infants.

Main Methods:

  • Literature review on vitamin A's role in infant development and deficiency.
  • Analysis of current practices and evidence for vitamin A supplementation in preterm infants.
  • Identification of research gaps concerning hepatic stores, functional status, and long-term outcomes.

Main Results:

  • Vitamin A supplementation is beneficial for newborns, reducing mortality.
  • Optimal vitamin A supplementation strategies for extremely preterm infants are not well-defined.
  • Early vitamin A supplementation is not consistently practiced in the UK despite evidence of benefit.

Conclusions:

  • Further research is urgently needed to establish optimal vitamin A supplementation protocols for preterm infants.
  • Studies should include quantification of hepatic vitamin A stores and functional assessments.
  • Long-term outcomes associated with vitamin A status in preterm infants require investigation.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...